Life Spine's sacroiliac joint fixation system, SImpact, received FDA clearance for posterior-oblique surgical approaches, the devicemaker said March 29.

The FDA granted nine orthopedic device approvals in February:

CFOs hold the top financial position in a company and are responsible for projecting the organization's financial standing as well as advising the CEO and board on strategic direction.

From the separation of its spine and dental businesses to its latest commercial product launch, here are four key developments from Zimmer Biomet in the first quarter:

France-based Spine Innovations reached a milestone with its lumbar disc replacement device, and it's setting its sights on the U.S. market.

Globus Medical co-founder Andrew Iott is among two new additions to Happe Spine's board of directors.

A $3.1 billion acquisition and four more developments from Stryker in the first quarter of 2022:

SeaSpine's NanoMetalene technology was implanted in its 50,000th case, the devicemaker said in a March 24 news release.

Intraoperative neuromonitoring company Assure Holdings hired two executives.

From new acquisitions to new leadership, here are seven developments from Medtronic in the first quarter of 2022:

Changes are afoot in the orthopedic device industry, as several medtech companies have appointed new CEOs in 2022.

The compensation of medtech leaders varies based on the company's size and market share. While some have a larger base salary, others have higher bonuses and stock option value. 

In the last week, two devicemakers have been named in spine and orthopedic lawsuits.

Since March 4, six spine and orthopedic devicemakers announced leadership moves.

The FDA granted 16 orthopedic device approvals in February:

Spine and orthopedic medtech companies are drawing the eyes and dollars of investors in 2022. Five companies have netted a total $123.6 million in deals so far.

Augmedics, developer of the Xvision augmented reality spine surgery system, began 2022 with a new CEO and recently added former Medtronic and Johnson & Johnson executives to its leadership team to help take the company to the next level.

Surgalign Holdings' global revenue for the fourth quarter decreased 16.8 percent year over year to $21.8 million as COVID-19 headwinds such as hospital staff shortages and procedural restrictions continued to affect surgical specialties.

Physiatrists — or physical medicine and rehabilitation physicians — collaborate with spine surgeons to develop personalized treatment plans for patients before and after surgery to optimize outcomes.

SeaSpine's 2021 revenue boost and three more updates from spine device companies in the last week: